• Home
  • About us
  • Contact Us
  • Advertise
  • Media Kit 2023
  • Editorial Calendar
  • Events
  • Comments
  • Posts
Health Care Asia LogoHealth Care Asia Logo
HCA Twitter HCA Meta Holiday ad
  • Home
  • About us
  • Contact Us
  • Advertise
  • Media Kit 2023
  • Editorial Calendar
  • Events

Multi-acting compound a new solution to drug-resistant prostate cancer

November 24, 2022

Multi-acting compound a new solution to drug-resistant prostate cancerThe growth of tumours in prostate cancer are fuelled by testosterone, contributing to a vicious cycle that eventually becomes resistant to standard treatments. Researchers from Washington University School of Medicine in St. Louis, or WUSTL, have found a drug compound that triggers immune cells to attack hard-to-treat prostate cancer and also cuts off the tumour’s ability to use testosterone.

Prostate cancer is known to be resistant to newer immunotherapies, which are intended to take the brakes off the immune system’s T cells to get them fighting cancerous invaders.

“Immunotherapy is the newest and most promising type of therapeutic for cancer right now, but even so, [immunotherapies such as] immune checkpoint inhibitors have failed to do much against most solid tumours, including prostate cancer,” said Dr. Nupam P. Mahajan, Professor of Surgery and research member of Siteman Cancer Center at Barnes-Jewish Hospital and WUSTL.

“This study was surprising because we found that this drug activates anti-cancer T cells in a novel way, and it also increases the T cells’ ability to penetrate the tumour. This could lead to a more effective strategy for patients whose cancers are hard to treat.”

The drug is called (R)-9b, a small molecule that blocks an oncogene i.e., a gene that drives cancer. The researchers initially attributed the drug’s success in mouse studies to its ability to reduce or eliminate androgen receptors in the prostate cancer cells. These receptors bind to testosterone and use the hormone to fuel tumour growth – the drug’s ability to eliminate the androgen receptor differs from standard drugs that reduce the amount of testosterone in the body, and other drugs that block the androgen receptor’s function as a transcription regulator.

But because the new drug was so effective, Mahajan and his colleagues suspected something more was going on. Then they noticed the drug also blocks a gene called ACK1.

The researchers developed a strain of mice that totally lacked this gene in order to study what happens when it’s missing. At first, the researchers were baffled by these mice. Mice missing an entire gene often have obvious problems. But these mice seemed fine. And when the researchers looked for tumour growth, they found very little. It was difficult to model cancer in these animals.

“In most of these mice, when we introduced cancer cells as we typically do, there was no trace of a tumour,” said Mahajan. “In the few that did develop tumours, the tumours were small compared to those of wild-type mice. This was the first clue that something important was happening in mice missing this gene. We found that they were able to mount a robust immune response against the cancer cells.”

When another set of mice with the ACK1 gene were implanted with human prostate tumours and given the drug that blocks this gene, it had the same effect: stimulating the immune system and producing increased levels of certain types of T cells known to attack cancer.

The drug also increased signaling molecules that allow the T cells to penetrate the tumour and kill cancer cells more effectively. The tumours in these (R)-9b treated mice were much smaller than those of mice in control groups.

Mahajan said the drug spurs multiple responses because of the nature of the gene it blocks. In short, ACK1’s roles in expression of the androgen receptor and in reigning in the immune system make it an appealing target for cancer therapy, especially against solid tumours with a hormonal growth component, such as prostate and breast cancers.

Mahajan and his colleagues are gathering data to apply for permission from the US Food and Drug Administration to test the drug in a clinical trial for patients with prostate cancer.

Health Care Asia
Home
Health Care Asia

Category: Pharmaceuticals

Email Facebook Google StumbleUpon Tumblr Twitter

Subscribe

If you enjoyed this article, subscribe to receive more just like it.

Privacy guaranteed. We never share your info.
Subscribe via RSS Feed Follow Us on Twitter Connect on Facebook

Comments are closed.

« Southeast Asian healthcare providers resolve cost pressures with single-speciality hospitals
Malaysia’s first public-private child care centre opens in Penang »
2023 MJN Media Kit
Subscribe to HCA for exclusive updates

Sponsored Content

6 Ways to improve your hearing and prevent hearing loss

6 Ways to improve your hearing and prevent hearing loss

Caring for your hearing health is essential regardless of your age. Not only does it reduce the risk of suffering from irreversible hearing loss... Read More

Top Viewed News

Sunway Sanctuary upscale senior living facility to open in 2023 in Kuala Lumpur

Sunway Sanctuary upscale senior living facility to open in 2023 in Kuala Lumpur

Sunway Healthcare Group (Sunway Healthcare) is set to launch its flagship senior living residence in response to increasing... Read More

A look into type 1 diabetes

A look into type 1 diabetes

The World Health Organisation (WHO) has mentioned that diabetes claims about three lives every minute worldwide – to narrow it down diabetes has been found to affect over 1 in 5 Malaysians... Read More

Regular breast cancer screening and self-examination helps your chances of survival

Regular breast cancer screening and self-examination helps your chances of survival

The prevalence of breast cancer is expected to cause more than 2.5 million deaths between 2020 and 2040, if nothing is done to avert it... Read More

Identifying childhood diabetes

Identifying childhood diabetes

Type 1 diabetes mellitus mostly afflicts young children – it is apparently the most common form of childhood diabetes in Malaysia... Read More

Free counters!

2023 -2024 Exhibitions



2023 Events


3-4 November
Eldercare Exhibition and Conference Asia (ELDEX Asia 2023)
Suntex Singapore Exhibition and Convention Centre
www.eldexasia.com


7-9 November
AI Asia Expo Philippines
Marriott Grand Ballroom Convention Center, Manila
www.aiasiaexpo.com


28 November 2023 @ 9:00 am to 29 November 2023 @ 5:30 pm
Hospital @ Home Asia
Singapore
www.hospitalmanagementasia.com


2024 Events


29 January – 1 February
Arab Health
Dubai World Trade Centre
www.arabhealthonline.com


6-7 March
Future Healthcare Asia
Berjaya Times Square, Malaysia
www.futurehealthcareasia.com


17-19 April
MEDEXPO Africa
Sarit Expo Centre, Nairobi, Kenya
www.medhospafrica.com


24-26 April Lab Indonesia
Lab Indonesia
Jakarta Convention Center, Jakarta, Indonesia
www.lab-indo.com


9-12 May
Vietnam Medi-Pharm
Friendship Cultural Palace , Hanoi
www.vietnammedipharm.vn


24-27 May
8th International Conference on Advance Care Planning
Singapore
www.acp-i2023.org


4-6 June
APHM
Kuala Lumpur Convention Centre
www.aphmconferences.com


14-16 June
China (Guangzhou) International Health Industry Expo
China Import and Export Fair Complex
www.ihe-china.com


19-21 June
CPhI China
SNIEC, Shanghai, China
www.cphi.com


19-21 June
Medical Device Development (MEDIX) – Osaka
INTEX Osaka
www.manufacturing-world.jp


27-28 June
OSH India South
Chennai Trade Center
www.oshindia.com


17-19 July
SE-Asian Healthcare & Pharma Show
Kuala Lumpur
www.abcex.com


27-30 August
Hospital Management Asia
Shangri-La Kuala Lumpur, Malaysia
www.hospitalmanagementasia.com


27-30 August
Hospital Management Asia
Shangri-La Kuala Lumpur, Malaysia
www.hospitalmanagementasia.com


11-13 September
Medical Fair Asia
Marina Bay Sands, Singapore
www.medicalfair-asia.com


11-13 September
Medical Fair Asia
Marina Bay Sands, Singapore
www.medicalfair-asia.com


11-13 September
Thailand LAB INTERNATIONAL
BITEC, Bangkok, Thailand
www.thailandlab.com


2-4 October
Medical Device Development (MEDIX) – Osaka
INTEX Osaka
www.manufacturing-world.jp


28-30 October
Saudi International Pharma Expo
Riyadh International Convention and Exhibition Center
www.saudipharmaexpo.com


28-30 October
Saudi International MedLab Expo
Riyadh International Convention and Exhibition Center
www.saudimedlabexpo.com


2025 Events


13-15 September
Medical Fair Thailand
BITEC, Bangkok
www.medicalfair-thailand.com


Tweets by @healthcareasia

© 2023 Healthcare Asia Daily News | Asia's Leading News and Information Source on Healthcare and Medical Industry, Medical Technology, Healthcare Business and R&D, Healthcare Events. Online since 2010. All rights reserved